A moisturing towelette is impregnated with a liquid formulation that, when applied to the skin, brightens colors of a tattoo disposed beneath the epidermis, while cleaning the tattoo and care for the skin.

A skin treatment composition is described comprising a cryopreserved blend of natural materials including at least two components selected from the group consisting of wheat grass juice, wheat grass pulp, shea butter, cocoa powder, rice flour, coffee, jojoba oil, hemp oil, castor oil, and sugarcane juice. The skincare treatment composition is applied with a specialty applicator that is frozen into the compound during processing. Methods of making, packaging and using the compositions also are disclosed.

A skin treatment composition is described comprising a cryopreserved blend of natural materials including at least two components selected from the group consisting of wheat grass juice, wheat grass pulp, shea butter, cocoa powder, rice flour, coffee, jojoba oil, hemp oil, castor oil, and sugarcane juice. The skincare treatment composition is applied with a specialty applicator that is frozen into the compound during processing. Methods of making, packaging and using the compositions also are disclosed.

The disclosure relates to compositions for treating keratin materials. The compositions comprise (a) at least one amphoteric surfactant; (b) at least one anionic surfactant system comprising (i) at least one acyl taurate, (ii) at least one acyl isethionate, and (iii) at least one additional anionic surfactant; (c) at least one nonionic surfactant chosen from alkyl(poly)glycosides; (d) optionally, at least one cationic compound; and (e) sodium chloride, wherein the weight ratio of the (b) at least one anionic surfactant system to (e) sodium chloride ranges from about 5:1 to about 15:1. The disclosure also relates to methods of using the compositions.

An aqueous personal care composition comprising: one or more amphoacetates; one or more glutamate surfactants selected from sodium lauroyl glutamate, dipotassium cocoyl glutamate, potassium lauryl/myristoyl glutamate and combinations thereof; and cocamide MIPA; wherein the composition is free of sulfates and ethoxylates.

An aqueous personal care composition comprising: one or more amphoacetates; one or more glutamate surfactants selected from sodium lauroyl glutamate, dipotassium cocoyl glutamate, potassium lauryl/myristoyl glutamate and combinations thereof; and cocamide MIPA; wherein the composition is free of sulfates and ethoxylates.

Described herein are complexes comprising a cationic antibacterial agent and a metal salt, personal care compositions comprising same; along with methods of making and using these complexes and compositions.

A sunscreen composition comprised of one or more sunscreen active agents encapsulated in a cellulose derived capsule wherein the composition can contain one or more additional agents. A sunscreen composition can be mixed with a bodywash, shampoo, conditioner, lotion, gel, soap, cream, hand sanitizer, spray or mousse and can be used by an individual during their normal hygiene processes, such as during a shower or bath or while applying a body product to their skin or hair.

Methods of treating itching with cannabinoid compounds are described herein. The cannabinoid compounds can include one or more of cannabidol (“CBD”), cannabichromene (“CBC”), cannabigerol (“CBG”), cannabinol (“CBN”), cannabicyclol (“CBL”), cannabidivarin (“CBDV”), cannabigerivarin (“CBGV”), and cannabicyclolic acid (“CBLA”) and variants thereof. The cannabinoid compounds can be antagonists to the receptors CHRM2, EDG3, and MRGPRX2. Compositions and articles including the cannabinoid compounds are further disclosed.

Methods of treating itching with cannabinoid compounds are described herein. The cannabinoid compounds can include one or more of cannabidol (“CBD”), cannabichromene (“CBC”), cannabigerol (“CBG”), cannabinol (“CBN”), cannabicyclol (“CBL”), cannabidivarin (“CBDV”), cannabigerivarin (“CBGV”), and cannabicyclolic acid (“CBLA”) and variants thereof. The cannabinoid compounds can be antagonists to the receptors CHRM2, EDG3, and MRGPRX2. Compositions and articles including the cannabinoid compounds are further disclosed.